Carlos Alberto
Flores Infante
Investigador Externo
Institut d'Investigació Biomédica de Bellvitge
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Institut d'Investigació Biomédica de Bellvitge (10)
2024
-
Association study of human leukocyte antigen variants and idiopathic pulmonary fibrosis
ERJ Open Research, Vol. 10, Núm. 1
-
Erratum: Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (Genome medicine (2023) 15 1 (22))
Genome medicine
-
Novel risk loci for COVID-19 hospitalization among admixed American populations
eLife, Vol. 13
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency
Nature, Vol. 623, Núm. 7988, pp. 803-813
-
Idiopathic pulmonary fibrosis and the role of genetics in the era of precision medicine
Frontiers in Medicine, Vol. 10
-
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Genome Medicine, Vol. 15, Núm. 1
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19
Science immunology, Vol. 6, Núm. 62
2020
-
Genome-wide association study of susceptibility to idiopathic pulmonary fibrosis
American Journal of Respiratory and Critical Care Medicine, Vol. 201, Núm. 5, pp. 564-574